Maclean, GB
Adam Maclean, Birmingham GB
Patent application number | Description | Published |
---|---|---|
20090178191 | POOL - A birthing pool for holding water comprises a floor | 07-16-2009 |
Adam Bryce Maclean, Chelmsford Essex GB
Patent application number | Description | Published |
---|---|---|
20110095939 | PROCESS AND SYSTEM FOR DETERMINING THE POSITION AND VELOCITY OF AN OBJECT - A process for determining the position and velocity of an object is disclosed. The process comprises: -generating a first burst of pulses at a first pulse repetition frequency and subsequently receiving a first set of signals characteristic of the range and velocity of the object; -generating a second burst of pulses at a second pulse repetition frequency and subsequently receiving a second set of signals characteristic of range and velocity of the object; -generating a first data set representative of range and corresponding velocity values from the first set of signals; -generating a second data set representative of range and corresponding velocity values from the second set of signals; -summing a magnitude of a signal strength from each of the first and second data sets at corresponding range and velocity values; and, -comparing the magnitude of the summed signal strengths to a threshold value. | 04-28-2011 |
Alasdair R. Maclean, Glasgow GB
Patent application number | Description | Published |
---|---|---|
20110195053 | Treatment of Non-Neuronal Cancer using HSV-1 Variants - A mutant herpes simplex virus which has been modified in the γ34.5 gene such that the gene is non-functional is used to treat a non-neuronal cancer such as a mesothelioma, ovarian carcinoma, bladder cancer or melanoma. Typically, the mutant herpes simplex virus has been modified within the BamHI restriction fragment of the long terminal repeat of the viral genome. | 08-11-2011 |
Alasdair Roderick Maclean, Glasgow GB
Patent application number | Description | Published |
---|---|---|
20100172872 | Treatment of Cancer Using HSV Mutant - Use as an anti-cancer agent of a mutant herpes simplex virus wherein the mutant virus comprises a modification in the γ34.5 gene in the long repeat region (R | 07-08-2010 |
20120141418 | Treatment of Melanoma Using HSV Mutant - Use as an anti-cancer agent of a mutant herpes simplex virus wherein the mutant virus comprises a modification in the γ34.5 gene in the long repeat region (R | 06-07-2012 |
Alistair Maclean, South Uist Western Isles GB
Patent application number | Description | Published |
---|---|---|
20110032518 | DETECTION ASSEMBLY - A detection assembly comprising: a body portion having a slot formed along at least a portion of a length thereof, the slot having a slot opening formed in an outer surface of the body portion, the slot opening being arranged to receive a sensor optical fibre through the slot opening; a sensor optical fibre constrained to lie in said slot and in juxtaposition with a plurality of protrusions; and at least one swell member, the swell member being configured to increase in volume in response to exposure to a target measurand, the detection assembly being arranged whereby an increase in a volume of said swell member causes said sensor optical fibre to be urged against at least one of said plurality of protrusions thereby to cause bending of said sensor optical fibre. | 02-10-2011 |
David James Maclean, East Cowes GB
Patent application number | Description | Published |
---|---|---|
20130266431 | METHOD OF FORMING A COMPOSITE STRUCTURE COMPRISING A FLANGE - Method forming a composite structure ( | 10-10-2013 |
Grant Maclean, Edinburgh GB
Patent application number | Description | Published |
---|---|---|
20160007293 | UNDERWATER POWER SAVING MECHANISM FOR USE IN AN COMMUNICATION NETWORK - An underwater communications network comprising a plurality of communication nodes operable to wirelessly communicate with at least one other node in the network, each node having a transceiver and an observation mechanism wherein the observation mechanism is operable to monitor signals received by the transceiver and upon reception of a first predetermined tone the observation mechanism outputs a signal operable to adjust the node from a passive operation mode to an active operation mode. Each node can be a discreet underwater device. | 01-07-2016 |
Iain Maclean, Aberdeen GB
Patent application number | Description | Published |
---|---|---|
20160005508 | CABLE FOR CONVEYING AN ELECTRICAL SUBMERSIBLE PUMP INTO AND OUT OF A WELL BORE - A cable for conveying an electrical submersible pump into and out of a well bore includes at least one strength member made of a composite material comprising a fiber reinforced plastic. A plurality of electrical conductors forming circumferential segments is disposed externally to the at least one strength member. A protective jacket encapsulates the at least one strength member and the plurality of electrical conductors. | 01-07-2016 |
Iain M. Maclean, Aberdeen GB
Patent application number | Description | Published |
---|---|---|
20080277573 | SENSING TOOL - A sensor system includes a carrier configured for a specific application; an electronics module mountable in a number of individual carriers; a feedthrough mountable in a number of individual carriers and in operable communication with the interface; a sensor mounting mountable in a number of individual carriers and in operable communication with the feedthrough; and a sensor array articulated to the sensor mounting. | 11-13-2008 |
Ian Kenneth Maclean, West Midlands GB
Patent application number | Description | Published |
---|---|---|
20090138472 | Method of Supplying Information Articles at a Website and a System for Supplying Such Articles | 05-28-2009 |
John Maclean, Kilmarnock GB
Patent application number | Description | Published |
---|---|---|
20140235667 | IMIDAZOPYRIDYL COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITORS - This invention relates to imidazopyridyl compounds of the structural formula: I or their pharmaceutically acceptable salts, wherein the variable are defined herein. The inventive compounds selectively inhibit aldosterone synthase. This invention also provides for pharmaceutical compositions comprising the compounds of Formula I or their salts as well as potentially to methods for the treatment, amelioration or prevention of conditions that could be treated by inhibiting aldosterone synthase. | 08-21-2014 |
20140288094 | PYRAZOLOPYRIDYL COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITORS - This invention relates to pyrazolopyridyl compounds of the structural formula: | 09-25-2014 |
John Maclean, Elderslie GB
Patent application number | Description | Published |
---|---|---|
20110153662 | MANAGING QUERIES - Managing queries performed on one or more data sources includes: storing at least a first query in a storage medium; selecting the first query for processing; instructing a query engine to process the first query on a first portion of data in the one or more data sources for a first query interval; receiving result data from the query engine based on processing the first query on the first portion of data; saving a state of the first query in the storage medium after the first query interval; instructing the query engine to process a second query during a second query interval after the first query interval; and instructing the query engine to process the first query on a second portion of data in the one or more data sources during a third query interval after the second query interval. | 06-23-2011 |
John Maclean, Kilmamock GB
Patent application number | Description | Published |
---|---|---|
20130317057 | ALDOSTERONE SYNTHASE INHIBITORS - The invention involves compounds of structural Formula (I) and the pharmaceutically acceptable salts thereof. The compounds of the invention are effective at selectively inhibiting CYP11B2, and are therefore useful for the treatment or prophylaxis of disorders that are associated with elevated aldosterone levels, including, but not limited to, hypertension and heart failure. | 11-28-2013 |
John Kinnaird Ferguson Maclean, Newhouse GB
Patent application number | Description | Published |
---|---|---|
20080255086 | Heterocyclic Derivatives - The present invention relates to a heterocyclic derivative according to formula I | 10-16-2008 |
20090131455 | HETEROCYCLIC DERIVATIVES - The present invention relates to a heterocyclic derivative according to formula I | 05-21-2009 |
20100113493 | (PYRROLIDIN-2-YL)PHENYL DERIVATIVES - The invention relates to (pyrrolidin-2-yl)phenyl derivatives having the general Formula I | 05-06-2010 |
John Kinnaird Ferguson Maclean, Kilmarnock GB
Patent application number | Description | Published |
---|---|---|
20120202781 | INDANE DERIVATIVES - The present invention relates to anindane derivative according to formula I wherein the variables are defined as in the specification, or to a pharmaceutically acceptable salt or solvate thereof. The present invention also relates to a pharmaceutical composition comprising one or more of said indane derivatives and to their use in therapy, for instance in the treatment or prevention of psychiatric diseases where an enhancement of synaptic responses mediated by AMPA receptors is required, including schizophrenia, depression and Alzheimer's disease. | 08-09-2012 |
John R. Maclean, Midlothian GB
Patent application number | Description | Published |
---|---|---|
20100079851 | OPTICAL PARAMETRIC OSCILLATOR - The present invention relates to an optical parametric oscillator. In particular, the present invention relates to a more optimal rotating image optical parametric oscillator. More specifically, there is described an optical parametric oscillator comprising six mirrored surfaces; wherein two of the mirrored surfaces are provided by a penta prism and the sequence of mirrors is operable to provide a predetermined rotation of a beam passing therethrough. | 04-01-2010 |
John Ronald Maclean, Basildon GB
Patent application number | Description | Published |
---|---|---|
20150232186 | DE-ICING SYSTEM AND METHOD - A de-icing system for a hemispherical protective housing mounted on an aircraft structure is described. The system can include a series of piezo-electric devices mounted at the boundary of the housing. The piezo-electric devices generate ultrasonic frequencies and resonance of the protective housing is induced. One of the piezo-electric devices senses the frequency generated in the protective housing and acts as part of a feedback loop to maintain structural resonance of the protective housing. The structural resonance of the protective housing prevents the build-up of ice. Additionally, higher power resonances can be generated to remove ice already built up on the protective housing. The system also enables detection of ice build-up on the protective housing by monitoring any change in the frequency required to maintain structural resonance of the protective housing. | 08-20-2015 |
Margaret Maclean, Glasgow GB
Patent application number | Description | Published |
---|---|---|
20140163086 | Methods of Modulating MicroRNAs in the Treatment of Pulmonary Arterial Hypertension - The present invention provides a method of treating or preventing pulmonary arterial hypertension in a subject in need thereof by administering to the subject an inhibitor of miR-145 expression or activity. Pharmaceutical compositions and kits comprising miR-145 inhibitors for treating pulmonary arterial hypertension are also disclosed. | 06-12-2014 |
Michelle Maclean, Glasgow GB
Patent application number | Description | Published |
---|---|---|
20080305004 | Inactivation of Gram-Positive Bacteria - A method for inactivating medically important Gram-positive bacteria including Methicillin-resistant | 12-11-2008 |
20100246169 | Lighting Device - A lighting device with at least one first-element that emits visible light at a wavelength and irradiance sufficient to inactivate one or more pathogenic bacterial species, and at least one second element that emits light of one or more longer wave-lengths to that of the first-element. The at least one second element has a higher illuminance than that of the at least one inactivating element or component. | 09-30-2010 |
20150182646 | INACTIVATION OF GRAM-POSITIVE BACTERIA - A method for inactivating medically important Gram-positive bacteria including Methicillin-resistant | 07-02-2015 |
Tim John Maclean, Bath GB
Timothy John Maclean, Bath And South East Somerset GB
Patent application number | Description | Published |
---|---|---|
20100160857 | Hand-Held Electronically Controlled Injection Device For Injecting Liquid Medications - A medication delivery device includes a housing, a door coupled to the housing and moveable between a closed position and an open position. The door permits insertion of a medication container, containing liquid medication, into the housing in the open position. A door opening mechanism is coupled to the door. A push member is axially moveable between a retracted position and a non-retracted position and located external to the medication container. The push member enters the medication container and pushes the liquid medication out of the medication container. A lock mechanism is coupled to the door opening mechanism and prevents opening of the door when the push member is in the non-retracted position inside the medication container, wherein the lock mechanism automatically unlocks the door opening mechanism when the push member is in the retracted position. | 06-24-2010 |
20110201998 | Hand-Held Electronically Controlled Injection Device For Injecting Liquid Medications - A medication delivery device includes a housing, a door coupled to the housing and moveable between a closed position and an open position. The door permits insertion of a medication container, containing liquid medication, into the housing in the open position. A door opening mechanism is coupled to the door. A push member is axially moveable between a retracted position and a non-retracted position and located external to the medication container. The push member enters the medication container and pushes the liquid medication out of the medication container. A lock mechanism is coupled to the door opening mechanism and prevents opening of the door when the push member is in the non-retracted position inside the medication container, wherein the lock mechanism automatically unlocks the door opening mechanism when the push member is in the retracted position. | 08-18-2011 |